Literature DB >> 22452389

Expression of cysteine protease cathepsin L is increased in endometrial cancer and correlates with expression of growth regulatory genes.

Maciej Skrzypczak1, Anette Springwald, Claus Lattrich, Julia Häring, Susanne Schüler, Olaf Ortmann, Oliver Treeck.   

Abstract

Proteases contribute to tumor invasion and metastasis by degrading basement membranes and extracellular matrix (ECM). In this study, we compared gene expression levels of two proteases, cysteine protease Cathepsin L2 (CTSL2) and matrix metalloproteinase MMP11, in human endometrium and endometrial cancer. Our data demonstrate CTSL2 transcript levels to be strongly elevated in endometrial cancer, particularly in G3 tumors. Furthermore, we observed a highly significant positive correlation of CTSL2 with expression of growth regulatory genes Ki-67, cyclin B1, MYBL2, p21/WAF, and HER2 receptor tyrosine kinase. Our data suggest that CTSL2 might be involved in progression of endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22452389     DOI: 10.3109/07357907.2012.672608

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  10 in total

Review 1.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

2.  Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression.

Authors:  Martina Tholen; Julia Wolanski; Britta Stolze; Marco Chiabudini; Mieczyslaw Gajda; Peter Bronsert; Elmar Stickeler; Sabine Rospert; Thomas Reinheckel
Journal:  J Biol Chem       Date:  2015-05-08       Impact factor: 5.157

Review 3.  Role of lysosomes in physiological activities, diseases, and therapy.

Authors:  Ziqi Zhang; Pengfei Yue; Tianqi Lu; Yang Wang; Yuquan Wei; Xiawei Wei
Journal:  J Hematol Oncol       Date:  2021-05-14       Impact factor: 17.388

Review 4.  Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites.

Authors:  Catharina Melzer; Juliane von der Ohe; Ralf Hass
Journal:  Biomed Res Int       Date:  2017-07-12       Impact factor: 3.411

5.  Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer.

Authors:  Naphannop Sereesongsaeng; Sara H McDowell; James F Burrows; Christopher J Scott; Roberta E Burden
Journal:  Breast Cancer Res       Date:  2020-12-09       Impact factor: 6.466

6.  High CTSL2 expression predicts poor prognosis in patients with lung adenocarcinoma.

Authors:  Junnian Song; Jindong Jiang; Na Wei; Zongsheng Duan; Gang Wang; Weiyun Pan
Journal:  Aging (Albany NY)       Date:  2021-09-23       Impact factor: 5.682

7.  Establishing a Macrophage Phenotypic Switch-Associated Signature-Based Risk Model for Predicting the Prognoses of Lung Adenocarcinoma.

Authors:  Jun Chen; Chao Zhou; Ying Liu
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

8.  New inhibitors of cathepsin V impair tumor cell proliferation and elastin degradation and increase immune cell cytotoxicity.

Authors:  Ana Mitrović; Emanuela Senjor; Marko Jukić; Lara Bolčina; Mateja Prunk; Matic Proj; Milica Perišić Nanut; Stanislav Gobec; Janko Kos
Journal:  Comput Struct Biotechnol J       Date:  2022-08-28       Impact factor: 6.155

9.  Bioprinting on Live Tissue for Investigating Cancer Cell Dynamics.

Authors:  Ariana D Suarez-Martinez; Marc Sole-Gras; Samantha S Dykes; Zachary R Wakefield; Kevin Bauer; Dima Majbour; Angela Bundy; Christine Pampo; Matthew E Burow; Dietmar W Siemann; Yong Huang; Walter Lee Murfee
Journal:  Tissue Eng Part A       Date:  2020-11-18       Impact factor: 4.080

10.  SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1.

Authors:  Junmei Cairns; James N Ingle; Lawrence D Wickerham; Richard Weinshilboum; Mohan Liu; Liewei Wang
Journal:  PLoS Genet       Date:  2017-10-02       Impact factor: 5.917

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.